Clinical Trials Browser

Phase 1/2 × Cryosurgery × Clear all

NCT05806385 2025-09-09

LOGIC

Phase 1/2 Not yet recruiting

Triple Negative Breast Neoplasms

NCT03325101 2025-06-12

Dendritic Cell Therapy With Pembrolizumab for Metastatic or Unresectable Melanoma

Phase 1/2 Terminated

7 enrolled 11 charts

Melanoma

NCT03035331 2025-05-16

Dendritic Cell Therapy, Cryosurgery, and Pembrolizumab in Treating Patients With Non-Hodgkin Lymphoma

Phase 1/2 Completed

11 enrolled 12 charts

LymphoidOther hematologic neoplasm

Lymphoma, Follicular, Lymphoma, Non-Hodgkin, Leukemia, Lymphocytic, Chronic, B-Cell, Lymphoma, T-Cell, Lymphoma, Large B-Cell, Diffuse, Lymphoma, B-Cell, Marginal Zone, Lymphoma, Mantle-Cell

NCT03183206 2020-07-13

Safety and Efficiency of γδ T Cell Against Breast Cancer

Phase 1/2 Completed

Breast Neoplasms

NCT03183219 2020-07-13

Safety and Efficiency of γδ T Cell Against Liver Cancer

Phase 1/2 Completed

Gastrointestinal

Liver Neoplasms

NCT03183232 2020-07-13

Safety and Efficiency of γδ T Cell Against Lung Cancer

Phase 1/2 Completed

Lung Neoplasms

NCT01065441 2020-01-22

Experimental Therapeutic Cancer Vaccine Created In-situ in Patients With Stage II-Stage IV Cancer

Phase 1/2 Completed

BreastDermatologicGastrointestinalGenitourinaryGynecologicSarcomaThoracic

Breast Neoplasms, Carcinoma, Non-Small-Cell Lung, Carcinoma, Renal Cell, Gastrointestinal Neoplasms, Melanoma, Ovarian Neoplasms, Prostatic Neoplasms, Sarcoma, Colorectal Neoplasms

NCT02018419 2020-01-22

MBC

Phase 1/2 Withdrawn

Breast Neoplasms

NCT04201990 2019-12-17

CCA-MPLC

Phase 1/2 Unknown

Lung Neoplasms

NCT01853618 2019-12-10

Tremelimumab With Chemoembolization or Ablation for Liver Cancer

Phase 1/2 Completed

61 enrolled 18 charts

Gastrointestinal

Biliary Tract Neoplasms, Carcinoma, Hepatocellular, Liver Neoplasms

NCT02843581 2019-09-12

Combination of Cryosurgery and NK Immunotherapy for Advanced Esophageal Cancer

Phase 1/2 Completed

Gastrointestinal

Esophageal Neoplasms

NCT02843607 2019-09-12

Combination of Cryosurgery and NK Immunotherapy for Advanced Kidney Cancer

Phase 1/2 Completed

Carcinoma, Renal Cell, Kidney Neoplasms

NCT02843802 2019-09-12

Combination of Cryosurgery and NK Immunotherapy for Advanced Liver Cancer

Phase 1/2 Completed

Gastrointestinal

Liver Neoplasms

NCT02843815 2019-09-12

Combination of Cryosurgery and NK Immunotherapy for Advanced Non-Small Cell Lung Cancer

Phase 1/2 Completed

Carcinoma, Non-Small-Cell Lung

NCT02844335 2019-09-12

Combination of Cryosurgery and NK Immunotherapy for Advanced Breast Cancer

Phase 1/2 Completed

Breast Neoplasms

NCT02849015 2019-09-12

Combination of Cryosurgery and NK Immunotherapy for Tumors in Transplanted Liver

Phase 1/2 Completed

Gastrointestinal

Carcinoma, Hepatocellular

NCT02849314 2019-09-12

Combination of Cryosurgey and NK Immunotherapy for Recurrent Laryngeal Cancer

Phase 1/2 Completed

Laryngeal Neoplasms

NCT02849327 2019-09-12

Combination of Cryosurgey and NK Immunotherapy for Recurrent Pharyngeal Cancer

Phase 1/2 Completed

Pharyngeal Neoplasms

NCT02849340 2019-09-12

Combination of Cryosurgey and NK Immunotherapy for Recurrent Cervical Cancer

Phase 1/2 Completed

Uterine Cervical Neoplasms

NCT02849353 2019-09-12

Combination of Cryosurgey and NK Immunotherapy for Recurrent Ovarian Cancer

Phase 1/2 Completed

Ovarian Neoplasms

NCT02849366 2019-09-12

Combination of Cryosurgery and NK Immunotherapy for Recurrent Sarcoma

Phase 1/2 Completed

Sarcoma

NCT02849379 2019-09-12

Combination of Cryosurgey and NK Immunotherapy for Recurrent Tongue Cancer

Phase 1/2 Completed

Tongue Neoplasms

NCT02545556 2016-08-29

Liver Cancer HepaSphere Combined With Cryosurgery

Phase 1/2 Completed

Gastrointestinal

Liver Neoplasms